390 related articles for article (PubMed ID: 26208712)
1. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation.
Wagner W; Ciszewski WM; Kania KD
Cell Commun Signal; 2015 Jul; 13():36. PubMed ID: 26208712
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of lactate receptor (HCAR1) affects cellular DNA repair capacity.
Wagner W; Kania KD; Ciszewski WM
DNA Repair (Amst); 2017 Apr; 52():49-58. PubMed ID: 28258841
[TBL] [Abstract][Full Text] [Related]
3. The lactate receptor (HCAR1/GPR81) contributes to doxorubicin chemoresistance via ABCB1 transporter up-regulation in human cervical cancer HeLa cells.
Wagner W; Kania KD; Blauz A; Ciszewski WM
J Physiol Pharmacol; 2017 Aug; 68(4):555-564. PubMed ID: 29151072
[TBL] [Abstract][Full Text] [Related]
4. Curcumin circumvent lactate-induced chemoresistance in hepatic cancer cells through modulation of hydroxycarboxylic acid receptor-1.
Soni VK; Shukla D; Kumar A; Vishvakarma NK
Int J Biochem Cell Biol; 2020 Jun; 123():105752. PubMed ID: 32325281
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
6. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
8. The lactate receptor, G-protein-coupled receptor 81/hydroxycarboxylic acid receptor 1: Expression and action in brain.
Morland C; Lauritzen KH; Puchades M; Holm-Hansen S; Andersson K; Gjedde A; Attramadal H; Storm-Mathisen J; Bergersen LH
J Neurosci Res; 2015 Jul; 93(7):1045-55. PubMed ID: 25881750
[TBL] [Abstract][Full Text] [Related]
9. HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications.
Zhao Y; Li M; Yao X; Fei Y; Lin Z; Li Z; Cai K; Zhao Y; Luo Z
Cell Rep; 2020 Dec; 33(10):108487. PubMed ID: 33296645
[TBL] [Abstract][Full Text] [Related]
10. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C
PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human cervical cancer cells.
Yang YC; Chao KS; Lin CP; Chen YY; Wang KL; Chen YJ
Int J Gynecol Cancer; 2009 May; 19(4):782-6. PubMed ID: 19509588
[TBL] [Abstract][Full Text] [Related]
12. Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.
Subramanian PD; An Z; Yu JR; Park WY
Cancer Chemother Pharmacol; 2016 Oct; 78(4):753-62. PubMed ID: 27535835
[TBL] [Abstract][Full Text] [Related]
13. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
[TBL] [Abstract][Full Text] [Related]
14. Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
Chavez-Blanco A; Segura-Pacheco B; Perez-Cardenas E; Taja-Chayeb L; Cetina L; Candelaria M; Cantu D; Gonzalez-Fierro A; Garcia-Lopez P; Zambrano P; Perez-Plasencia C; Cabrera G; Trejo-Becerril C; Angeles E; Duenas-Gonzalez A
Mol Cancer; 2005 Jul; 4(1):22. PubMed ID: 16001982
[TBL] [Abstract][Full Text] [Related]
15. Lactate receptor HCAR1 regulates neurogenesis and microglia activation after neonatal hypoxia-ischemia.
Kennedy L; Glesaaen ER; Palibrk V; Pannone M; Wang W; Al-Jabri A; Suganthan R; Meyer N; Austbø ML; Lin X; Bergersen LH; Bjørås M; Rinholm JE
Elife; 2022 Aug; 11():. PubMed ID: 35942676
[TBL] [Abstract][Full Text] [Related]
16. The Lactate Receptor HCAR1 Modulates Neuronal Network Activity through the Activation of G
de Castro Abrantes H; Briquet M; Schmuziger C; Restivo L; Puyal J; Rosenberg N; Rocher AB; Offermanns S; Chatton JY
J Neurosci; 2019 Jun; 39(23):4422-4433. PubMed ID: 30926749
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of L- and D-lactate on memory encoding and consolidation: Potential role of HCAR1 signaling.
Scavuzzo CJ; Rakotovao I; Dickson CT
Neurobiol Learn Mem; 2020 Feb; 168():107151. PubMed ID: 31881352
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
[TBL] [Abstract][Full Text] [Related]
19. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
20. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
